Health authorities will use the vaccines, developed by Cuba’s Finlay Vaccines Institute (IFV), to provide protection against reinfection by the Omicron variant of the SARS-CoV-2 coronavirus, according to the digital edition of the newspaper Últimas Noticias.

The first in the world specially designed to re-stimulate immunity previously induced by other Covid-19 vaccines or by natural infection, Soberana Plus was also used in Cuba as a booster dose in the immunization scheme conceived with two doses of Soberana 02.

In 2021, Venezuela also incorporated the Cuban-made Abdala vaccine for the protection of the adult population in a complete cycle of three doses, as part of a campaign that initially included the Sputnik V and Sinopharm vaccines, developed by Russia and China, respectively.

Both Abdala and Soberana 02 are among the vaccines approved by Venezuelan health authorities to be administered to children over 2 years of age, another example of the confidence placed in the effectiveness of these products resulting from Cuban science.

jg/abo/mgt/wup